How Eric Lefkofsky’s Start-Up Company Is Changing Healthcare.

Eric Lefkofsky is the man behind the big data craze that is sweeping through the world of technology. Lefkofsky is making headlines out of Chicago’s busy tech sector with his new startup, Tempus. Tempus was co-founded by Lefkofsky back in 2015 and over the past three years, the company has continued to grow by leaps and bounds, with more than 30 new employees being added to the roster on a monthly basis. Tempus is seeking to provide a solution to the world of cancer care in the form of streamlined databases filled with patient care information. Tempus recently hit a financial milestone which makes it all the more likely that the company has some measure of success in their mission.

Tempus is seeking to funnel molecular data into a technological database that can be accessed by medical professionals and patients who want to stay informed regarding the cancer care treatment that they are undergoing. The goal here is simple and it is the bedrock by which Lefkofsky has been helping to build up his company. Lefkofsky wants to make information so accessible that healthcare professionals are able to discern patterns within treatment plans that can make their job easier and, in return, help to save lives.

One of the most recent reasons for optimism at Tempus comes by way of their newly minted Unicorn status. After another round of private investing, Tempus managed to cross the $210 million mark. Companies like T. Rowe Price Associates, Kinship Trust Co, New Enterprise Associates and Revolution Growth all combined to add another $80 million to Tempus’ bottom line. This recent allotment of donations helped to push Tempus’ evaluation to north of $1 billion. By reaching this number, Tempus was able to become one of the few Chicago-based startups that managed to earn the title of Unicorn status.

Lefkofsky has largely stayed focused on mission at hand but he hasn’t been shy when it comes to revealing optimism for the future of the Tempus project. Lefkofsky points out that Tempus is existing within a ‘paradigm shift’ that could be changing the expectations that patients and healthcare professionals have.

To Know More Click Here